GA-68 dotatate diagnostic radiopharmaceuticals

Ended Purchase Order Awarded Last action

Contract number
36C26124P0007
Awardee
Awarding agency
Obligated
$14,250

Award facts

Opportunity
Contract value 6% obligated
  • $14,250.00 Current, with exercised options
  • $220,400.00 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Competed under SAP · 2 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Norcross, GA, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00002 -$3,150
Supplemental Agreement for work within scope P00001 -$188,750
Original award $206,150

About this award

Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, was awarded a firm fixed-price purchase order valued at $220,400 by Veterans Integrated Service Network 21 (VISN 21) of the Department of Veterans Affairs on October 1, 2023. The contract calls for the supply of Gallium-68 Dotatate (Netspot) radiopharmaceutical doses and associated materials to support nuclear medicine diagnostic imaging procedures at VA Palo Alto Health Care System. The award is non-set-aside and requires the vendor to deliver prepared doses within 30 minutes of scheduled calibration time while maintaining Nuclear Regulatory Commission licensing and regulatory compliance. The contract is scheduled to run through September 30, 2024, with pricing structured at $70 per dose and a $7 cancellation fee for cancellations made less than 24 hours before the scheduled delivery time.

Jubilant Radiopharma, a small disadvantaged business and subsidiary of Jubilant Life Sciences Limited, serves as a critical supplier of specialized radiopharmaceuticals to the VA nationwide. The company holds extensive Indefinite Delivery Vehicle contracts across multiple VA regional networks with ceiling values ranging from $220,000 to $39.8 million, positioning it as a key provider of nuclear medicine products essential for diagnostic imaging and cancer treatment support across the VA's healthcare system. This purchase order represents one of numerous delivery orders and task orders the company fulfills under its established contract vehicles with the Veterans Health Administration.

Quick answers

Who was awarded contract 36C26124P0007?

36C26124P0007 was awarded to Jubilant Draximage Radiopharmacies, Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on October 1, 2023.

How much is contract 36C26124P0007 worth?

The government has obligated $14,250 on 36C26124P0007. Its potential value, with all options, is $220,400.

Was contract 36C26124P0007 competed?

The extent of competition for 36C26124P0007 was competed under sap. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award